368866-31-3 Usage
Description
(2S)-([(9H-fluoren-9-yl)methoxy]carbonylamino)(oxan-4-yl)acetic acid is a complex organic molecule characterized by the presence of amino, carboxylic, and ether functional groups. It features a fluorenyl group attached to a carbonyl group, which is then connected to an amino acid derivative. Additionally, the molecule contains an oxan-4-yl group linked to an acetic acid moiety. This intricate structure suggests potential applications in the pharmaceutical industry, warranting further research to explore its properties and uses in drug development.
Uses
Used in Pharmaceutical Industry:
(2S)-([(9H-fluoren-9-yl)methoxy]carbonylamino)(oxan-4-yl)acetic acid is used as a potential candidate for drug development due to its unique molecular structure and functional groups. Its fluorenyl and carbonyl components, along with the amino acid and oxan-4-yl groups, may contribute to its interaction with biological targets, offering opportunities for the creation of new therapeutic agents. Further research is necessary to understand its full potential and optimize its application in medicinal chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 368866-31-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,6,8,8,6 and 6 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 368866-31:
(8*3)+(7*6)+(6*8)+(5*8)+(4*6)+(3*6)+(2*3)+(1*1)=203
203 % 10 = 3
So 368866-31-3 is a valid CAS Registry Number.
368866-31-3Relevant articles and documents
MASP INHIBITORY COMPOUNDS AND USES THEREOF
-
Page/Page column 115, (2020/11/23)
The present invention relates to novel Mannose-binding lectin (MBL)-associated serine protease (MASP) inhibitory compounds, as well as analogues and derivatives thereof, to processes for the preparation thereof, to the use thereof alone or in combinations for treatment and/or prevention of diseases and to the use thereof for production of medicaments for treatment and/or prevention of diseases, especially for treatment and/or prevention of renal and cardiovascular disorders and of ischemia reperfusion injuries.
